As of June 21, 2025, Captor Capital Corp (CPTR.CN) reports a Current Ratio of 2.61.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Captor Capital Corp's Current Ratio
Over recent years, Captor Capital Corp's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-03-31 | 2.61 |
| 2023-03-31 | 2.61 |
| 2022-03-31 | 2.24 |
| 2021-03-31 | 3.64 |
| 2020-03-31 | 6.62 |
This slight downward trend highlights how Captor Capital Corp manages its short-term assets and liabilities over time.
Comparing Captor Capital Corp's Current Ratio to Peers
To better understand Captor Capital Corp's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Captor Capital Corp (CPTR.CN) | 2.61 |
| Titan Pharmaceuticals Inc (TTNP) | 6.08 |
| 48North Cannabis Corp (NRTH.V) | 3.96 |
| Polydex Pharmaceuticals Ltd (POLXF) | 3.73 |
| Sonoma Pharmaceuticals Inc (SNOA) | 3.37 |
| Invictus MD Strategies Corp (GENE.H.V) | 3.05 |
Compared to its competitors, Captor Capital Corp's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.